Valneva SE (VALN) Change in Working Capital (2021 - 2026)
Valneva SE (VALN) posted Change in Working Capital of $20.2 million for Q1 2026, up 16442.61% sequentially from -$123388.6 in Q4 2025, and up 308.94% YoY from $4.9 million in Q1 2025.
Valneva SE (VALN) Change in Working Capital (2021 - 2026) Analysis & Trends
Valneva SE has reported Change in Working Capital for 6 years, with the latest figure at $20.2 million in Q1 2026.
- Quarterly Change in Working Capital rose 308.94% year-over-year to $20.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.6 million (up 134.03% YoY) and the FY2025 annual result came in at $1.7 million, down 86.12% from the prior year.
- Change in Working Capital climbed to $20.2 million in Q1 2026 per VALN's latest filing, from -$123388.6 in the prior quarter.
- Over five years, Change in Working Capital peaked at $46.5 billion in Q3 2023 and troughed at -$46.6 billion in Q2 2023.
- A 5-year average of $10.8 million and a median of -$123388.6 in 2025 frame the typical range for Change in Working Capital.
- The widest YoY moves for Change in Working Capital: up 41843.2% in 2023, down 29580.84% in 2023.
- Over 5 years, Change in Working Capital stood at -$51.6 million in 2022, then surged by 598.31% to $257.1 million in 2023, then slumped by 80.68% to $49.7 million in 2024, then plunged by 100.25% to -$123388.6 in 2025, then soared by 16442.61% to $20.2 million in 2026.
- According to Business Quant data, Change in Working Capital over the past three periods registered $20.2 million, -$123388.6, and $10.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Valneva SE | 618.67 Mn | 477.41 Mn | 1.86 Mn | -45.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -45.71 Mn |
| Jun 30, 2026 | -45.71 Mn |
| Mar 31, 2026 | 20.16 Mn |
| Mar 31, 2026 | 20.16 Mn |
| Dec 31, 2025 | -123,388.61 |
| Dec 31, 2025 | -123,388.61 |
| Sep 30, 2025 | 10.95 Mn |
| Sep 30, 2025 | 10.95 Mn |
| Jun 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 1.57 Mn |
| Mar 31, 2025 | -9.65 Mn |
| Mar 31, 2025 | -9.65 Mn |
| Dec 31, 2024 | 49.66 Mn |
| Dec 31, 2024 | 49.66 Mn |
| Sep 30, 2024 | -4.31 Mn |
| Sep 30, 2024 | -4.31 Mn |
| Jun 30, 2024 | -21.79 Mn |
| Jun 30, 2024 | -21.79 Mn |
| Mar 31, 2024 | -11.87 Mn |
| Mar 31, 2024 | -11.87 Mn |